R. S. Hotchkiss, G. Monneret, and D. Payen, Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach, Lancet Infect Dis, vol.13, pp.260-268, 2013.

T. Van-der-poll, F. L. Van-de-veerdonk, B. P. Scicluna, and M. G. Netea, The immunopathology of sepsis and potential therapeutic targets, Nat Rev Immunol, vol.17, pp.407-427, 2017.

L. F. Gentile, A. G. Cuenca, P. A. Efron, D. Ang, A. Bihorac et al., Persistent inflammation and immunosuppression: a common syndrome and new horizon for surgical intensive care, J Trauma Acute Care Surg, vol.72, pp.1491-501, 2012.

C. Meisel, J. C. Schefold, R. Pschowski, T. Baumann, K. Hetzger et al.,

. Granulocyte-macrophage, Colony-stimulating Factor to Reverse Sepsisassociated Immunosuppression, Am J Respir Crit Care Med, vol.180, pp.640-648, 2009.

M. W. Hall, N. L. Knatz, C. Vetterly, S. Tomarello, M. D. Wewers et al., Immunoparalysis and nosocomial infection in children with multiple organ dysfunction syndrome, Intensive Care Med, vol.37, pp.525-557, 2010.

A. M. Drewry, E. A. Ablordeppey, E. T. Murray, E. R. Beiter, A. H. Walton et al., Comparison of monocyte human leukocyte antigen-DR expression and stimulated tumor necrosis factor alpha production as outcome predictors in severe sepsis: a prospective observational study, Critical Care, vol.20, pp.260-270, 2016.

G. Monneret, A. Lepape, N. Voirin, J. Bohé, F. Venet et al., Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock, Intensive Care Med, vol.32, pp.1175-83, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00428008

A. Lukaszewicz, M. Grienay, M. Resche-rigon, R. Pirracchio, V. Faivre et al., Monocytic HLA-DR expression in intensive care patients: interest for prognosis and secondary infection prediction, Crit Care Med, vol.37, pp.2746-52, 2009.

C. Landelle, A. Lepape, N. Voirin, E. Tognet, F. Venet et al., Low monocyte human leukocyte antigen-DR is independently associated with nosocomial infections after septic shock, Intensive Care Med, vol.36, pp.1859-66, 2010.
DOI : 10.1007/s00134-010-1962-x

URL : https://hal.archives-ouvertes.fr/hal-00539253

M. W. Hall, S. M. Geyer, C. Guo, A. Panoskaltsis-mortari, P. Jouvet et al., Innate Immune Function and Mortality in Critically Ill Children With Influenza, Crit Care Med, vol.41, pp.224-260, 2013.

J. A. Muszynski, R. Nofziger, K. Greathouse, J. Nateri, L. Hanson-huber et al., Innate Immune Function Predicts the Development of Nosocomial Infection in Critically Injured Children, Shock, vol.42, pp.313-334, 2014.

M. S. Winkler, A. Rissiek, M. Priefler, E. Schwedhelm, L. Robbe et al., Human leucocyte antigen (HLA-DR) gene expression is reduced in sepsis and correlates with impaired TNF? response: A diagnostic tool for immunosuppression?, PLoS ONE, vol.12, pp.182427-182441, 2017.

D. Duffy, V. Rouilly, V. Libri, M. Hasan, B. Beitz et al., Functional Analysis via Standardized Whole-Blood Stimulation Systems Defines the Boundaries of a Healthy Immune Response to Complex Stimuli, Immuni, vol.40, pp.436-50, 2014.
URL : https://hal.archives-ouvertes.fr/pasteur-01384537

W. Heagy, K. Nieman, C. Hansen, M. Cohen, D. Danielson et al., Lower levels of whole blood LPS-stimulated cytokine release are associated with poorer clinical outcomes in surgical ICU patients, Surg Infect (Larchmt), vol.4, pp.171-80, 2003.

M. Ploder, L. Pelinka, C. Schmuckenschlager, B. Wessner, H. J. Ankersmit et al., Lipopolysaccharide-induced tumor necrosis factor alpha production and not monocyte human leukocyte antigen-DR expression is correlated with survival in septic trauma patients, Shock, vol.25, pp.129-163, 2006.

M. L. Allen, J. A. Hoschtitzky, M. J. Peters, M. Elliott, A. Goldman et al., Interleukin-10 and its role in clinical immunoparalysis following pediatric cardiac surgery, Crit Care Med, vol.34, pp.2658-65, 2006.

L. A. Van-vught, M. A. Wiewel, A. J. Hoogendijk, B. P. Scicluna, H. Belkasim-bohoudi et al., Reduced Responsiveness of Blood Leukocytes to Lipopolysaccharide Does not Predict Nosocomial Infections in Critically Ill Patients, Shock, vol.44, pp.110-114, 2015.

J. A. Muszynski, R. Nofziger, M. Moore-clingenpeel, K. Greathouse, L. Anglim et al., Early Immune Function and Duration of Organ Dysfunction in Critically Ill Septic Children, Am J Respir Crit Care Med, 2018.

A. B. Maddux, T. D. Hiller, K. H. Overdier, L. L. Pyle, and I. S. Douglas, Innate Immune Function and Organ Failure Recovery in Adults With Sepsis, J Intensive Care Med, vol.11, p.885066617701903, 2017.

A. Marchant, M. L. Alegre, A. Hakim, G. Piérard, G. Marécaux et al., Clinical and biological significance of interleukin-10 plasma levels in patients with septic shock, Journal of Clinical Immunology, vol.15, pp.266-73, 1995.

O. Rigato and R. Salomao, Impaired Production of Interferon-gamma and Tumor Necrosis Factor-alpha but not of Interleukin 10 in Whole Blood of Patients with Sepsis, Shock, vol.19, pp.113-119, 2003.

W. Ertel, J. P. Kremer, J. Kenney, U. Steckholzer, D. Jarrar et al., Downregulation of proinflammatory cytokine release in whole blood from septic patients, Blood, vol.85, pp.1341-1348, 1995.

W. Haupt, H. Zirngibl, J. Riese, A. Stehr, H. J. Linde et al., Depression of Tumor Necrosis Factor-a, Interleukin-6, and Interleukin-10 Production: A Reaction to the Initial Systemic Hyperactivation in Septic Shock, Journal of Investigative Surgery, vol.10, pp.349-55, 2009.

R. C. Bone, R. A. Balk, F. B. Cerra, R. P. Dellinger, A. M. Fein et al., Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis, The ACCP/SCCM Consensus Conference Committee, vol.101, pp.1644-55, 1992.

S. Jouneau, M. Bonizec, C. Belleguic, B. Desrues, G. Brinchault et al., Anti-Inflammatory Effect of Fluvastatin on IL-8 Production Induced by Pseudomonas aeruginosa and Aspergillus fumigatus Antigens in Cystic Fibrosis, PLoS ONE, vol.6, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00680962

W. R. Mccabe, Gram-Negative Bacteremia, Arch Intern Med, vol.110, p.847, 1962.

J. Cavaillon and M. Adib-conquy, Bench-to-bedside review: endotoxin tolerance as a model of leukocyte reprogramming in sepsis, Crit Care, vol.10, p.233, 2006.

M. Kox, S. De-kleijn, J. C. Pompe, B. P. Ramakers, M. G. Netea et al., Differential ex vivo and in vivo endotoxin tolerance kinetics following human endotoxemia*, Crit Care Med, vol.39, 2011.

M. Adib-conquy, C. Adrie, C. Fitting, O. Gattolliat, R. Beyaert et al., Upregulation of MyD88s and SIGIRR, molecules inhibiting Toll-like receptor signaling, in monocytes from septic patients*, Crit Care Med, vol.34, pp.2377-85, 2006.

S. A. Stanilova, Z. T. Karakolev, G. S. Dimov, Z. G. Dobreva, L. D. Miteva et al., High interleukin 12 and low interleukin 10 production after in vitro stimulation detected in sepsis survivors, Intensive Care Med, vol.31, pp.401-408, 2005.

G. Monneret, M. Finck, F. Venet, A. Debard, J. Bohé et al., The anti-inflammatory response dominates after septic shock: association of low monocyte HLA-DR expression and high interleukin-10 concentration, Immunology Letters, vol.95, pp.193-201, 2004.

J. A. Kellum, L. Kong, M. P. Fink, L. A. Weissfeld, D. M. Yealy et al., Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study, Arch Intern Med, vol.167, pp.1655-63, 2007.

J. A. Kellum, F. Pike, D. M. Yealy, D. T. Huang, N. I. Shapiro et al., Relationship Between Alternative Resuscitation Strategies, Host Response and Injury Biomarkers, and Outcome in Septic Shock, Crit Care Med, vol.45, pp.438-483, 2017.

J. F. Frencken, L. A. Van-vught, L. M. Peelen, D. Ong, K. Klouwenberg et al., An Unbalanced Inflammatory Cytokine Response Is Not Associated With Mortality Following Sepsis, Crit Care Med, vol.45, pp.493-502, 2017.

H. G. Gomez, S. M. Gonzalez, J. M. Londoño, N. A. Hoyos, C. D. Niño et al., Immunological Characterization of Compensatory Anti-Inflammatory Response Syndrome in Patients With Severe Sepsis, Crit Care Med, vol.42, pp.771-80, 2014.

J. Chen, A. H. Bruns, H. K. Donnelly, and R. G. Wunderink, Comparative in vitro stimulation with lipopolysaccharide to study TNF? gene expression in fresh whole blood, fresh and frozen peripheral blood mononuclear cells, Journal of Immunological Methods, vol.357, pp.33-40, 2010.

C. W. Thurm and J. F. Halsey, Measurement of cytokine production using whole blood, Curr Protoc Immunol, 2005.

E. Segre and J. N. Fullerton, Stimulated Whole Blood Cytokine Release as a Biomarker of Immunosuppression in the Critically Ill, Shock, vol.45, pp.490-494, 2016.

M. Ouagued, C. Martin-chouly, G. Brinchault, C. Leportier-comoy, A. Depincé et al., The novel phosphodiesterase 4 inhibitor, CI-1044, inhibits LPS-induced TNF-alpha production in whole blood from COPD patients, Pulm Pharmacol Ther, vol.18, pp.49-54, 2005.

H. Bruunsgaard, A. N. Pedersen, M. Schroll, P. Skinhoj, and B. K. Pedersen, Impaired production of proinflammatory cytokines in response to lipopolysaccharide (LPS) stimulation in elderly humans, Clin Exp Immunol, vol.118, pp.235-276, 1999.

M. E. Starr and H. Saito, Sepsis in old age: review of human and animal studies, A&D, vol.5, pp.126-162, 2014.

K. Kaukonen, M. Bailey, S. Suzuki, D. Pilcher, and R. Bellomo, Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, Jama, vol.311, pp.1308-1324, 2000.

J. Vincent, J. C. Marshall, S. A. Namendys-silva, B. François, I. Martin-loeches et al., Assessment of the worldwide burden of critical illness: the intensive care over nations (ICON) audit, Lancet Respir Med, vol.2, pp.380-386, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01952438

C. Rhee, R. Dantes, L. Epstein, D. J. Murphy, C. W. Seymour et al., Incidence and Trends of Sepsis in US Hospitals Using Clinical vs Claims Data, Jama, vol.318, pp.1241-1250, 2009.

L. A. Van-vught, K. Klouwenberg, P. Spitoni, C. Scicluna, B. P. Wiewel et al., Risk Factors, and Attributable Mortality of Secondary Infections in the Intensive Care Unit After Admission for Sepsis, Jama, vol.315, pp.1469-1480, 2016.

A. M. Drewry, E. A. Ablordeppey, E. T. Murray, E. R. Beiter, A. H. Walton et al., Comparison of monocyte human leukocyte antigen-DR expression and stimulated tumor necrosis factor alpha production as outcome predictors in severe sepsis: a prospective observational study, Critical Care, vol.20, pp.260-270, 2016.